Herantis Pharma Plc (HRTIS) - Financial Analysis Review

Summary

Herantis Pharma Plc (Herantis Pharma), formerly Hermo Pharma is a specialty pharmaceutical company that develops novel pharmaceutical products for unmet clinical needs. The company concentrates on developing drugs for dry eye, Parkinson's disease, and secondary lymphedema. It offers pipeline products such as CDNF for amyotrophic lateral sclerosis, CDNF for Parkinsons disease, Cis-UCA emulsion cream for atopic dermatitis, Cis-UCA eye drops for dry eye, and lymfactin for secondary lymphedema. The companys lymfactin recovers the damaged lymph system by reconstituting lymphatic vasculature. It has presence in Helsinki and Turku. Herantis Pharma is headquartered in Helsinki, Finland

GlobalData's Herantis Pharma Plc (HRTIS) - Financial Analysis Review provides a comprehensive insight into the company's history, business structure and operations. The report contains information on the company's key employees, key competitors and major products and services, as well as detailed financial ratios for the last 5 years.

Herantis Pharma Plc Key Recent Developments:

Feb 25,2016: Decision in arbitration proceedings between Herantis Pharma subsidiary Laurantis Pharma and Finvector Vision Therapies
Jan 04,2016: Herantis Pharma elaborates on its outlook for 2016
Dec 31,2015: Herantis Pharma Financial Statements Release January 1-December 31, 2015
Jun 30,2015: Interim report January 1-June 30, 2015: Financially stable new investments in regenerative medicine: CDNF and Lymfactin
Mar 18,2015: Herantis Pharma announces an internationally renowned Scientific Advisory Board with Professor Jonathan Knowles as Chairman


This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope
- Business description - A detailed description of the company's operations and business divisions.
- Company history - Progression of key events associated with the company.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Executive biographies - A brief summary of the executives' employment history.
- Key operational heads - A list of personnel heading key departments/functions.
- Important locations and subsidiaries - A list of key locations and subsidiaries of the company, including contact details.
- Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note: Some sections may be missing if data is unavailable for the company.

Reasons to Buy

- Gain key insights into the company for academic or business research purposes. Key elements such as detailed business description and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report's analysis of the company's business structure, operations, major products and services.
- Examine potential investment and acquisition targets with this report's detailed insight into the company's business, financial and operational performance. Financial ratios presented for major public companies in the report inclu